Delray Beach – October 12, 2026 -- The global rodenticides market is estimated at USD 6.61 billion in 2026 and is projected to reach USD 8.83 billion by 2031, a 6.0% CAGR, according to MarketsandMarkets.
North America held 31.3% of 2025 revenue as Europe is expected to keep a significant share
North America accounted for the largest regional revenue share in 2025, at 31.3%. Europe is expected to hold a significant share of the global market, driven by rising rodent infestations in urban, industrial and agricultural sectors and by stringent food safety and public health rules. Well-developed pest control services and efficient distribution systems add to its position. Asia Pacific is identified as an important growth region, supported by rapid urbanization, expanding agriculture and food-storage infrastructure.
Urban infestations and food-safety rules drive demand
Growth is tied to deteriorating infrastructure and the rapid expansion of the food and beverage and logistics sectors, which have increased rodent presence in urban, commercial and industrial areas. Food safety and public health regulations are pushing businesses toward more effective rodent control. Demand is also supported by the adoption of professional pest-management services.
Chemical products and pellets lead segments
The chemical segment is estimated to hold a significant share by type, owing to proven efficacy and broad availability. Anticoagulants such as brodifacoum, bromadiolone and difenacoum remain widely used. Non-anticoagulants such as cholecalciferol and zinc phosphide serve specific pest-control requirements.
By application mode, pellets are also expected to hold a significant share and register the highest CAGR. Pellets allow controlled-dose application, which reduces the risk of over-application, and their stability and long shelf life add to their appeal. They are available in both anticoagulant and non-anticoagulant chemistries.
Other segment forecasts:
- Software & services: highest CAGR by type, at 6.6% from 2026 to 2031.
- Mice: highest CAGR by target rodent type, at 6.2%.
- Urban centers: estimated to dominate by end use.
Top five suppliers control roughly 34–40% of revenue
BASF SE, Bayer AG, Syngenta AG, Rentokil Initial plc and UPL Limited collectively account for approximately 34–40% of market revenue, a moderately concentrated landscape. The remaining 60–66% is spread among other global and regional manufacturers, specialized rodenticide companies and pest-management providers. Positioning depends on product portfolios, geographic reach, distribution networks, regulatory approvals and alternative-technology development.
SenesTech raised USD 10.7 million in 2025 for fertility-control alternatives
SenesTech, Inc. raised USD 4.4 million in gross proceeds through a warrant exercise in July 2025 and USD 6.3 million in August 2025. The company is commercializing Evolve Rat and Evolve Mouse, which use fertility-control technology as an alternative to lethal rodenticides.
M&A activity centers on broadening product portfolios, expanding geographic presence, enhancing manufacturing capabilities and accessing new rodent-control technologies. Companies are seeking to pair established anticoagulants with non-anticoagulant, species-specific and fertility-control products. The report expects continued consolidation and strategic investment across rodenticides and the broader pest-management industry.